Globeimmune
Louisville, US · Delaware corporation
Founders & leadership
CJ
C. Jeffrey DekkerExecutive
TC
Timothy C. RodellExecutive
CJ
C Jeffrey DekkerExecutive
TC
Timothy C RodellExecutive
KA
Kirk A ChristoffersenExecutive
Board
CK
Charles KimBoard director
JB
Jerel BanksBoard director
PA
Paul A MieyalBoard director
DJ
Dan J MitchellBoard director
PS
Pennina SaferBoard director
AJ
Augustine J LawlorBoard director
RE
Ralph E ChristoffersenBoard director
Reported raises · per SEC filings
Form D private placements$10M disclosed across 3 rounds · 2013–2017
▶$2.1MraisedMar 2017 · 1 investors · PharmaceuticalsRule 506(b)
▶$2.1MraisedMar 2017 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Charles KimDirector
- C. Jeffrey DekkerExecutive Officer
- Jerel BanksDirector
- Timothy C. RodellDirector
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedJun 2014 · 110 investors · PharmaceuticalsRule 506(b)
▶$7.5MraisedJun 2014 · 110 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- J William FreytagDirector
- C Jeffrey DekkerExecutive Officer
- Paul A MieyalDirector
- Dan J MitchellDirector
- Pennina SaferDirector
- Augustine J LawlorDirector
- Ralph E ChristoffersenDirector
- Timothy C RodellExecutive Officer, Director
- Kirk A ChristoffersenExecutive Officer
- S Edward TorresDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- Sales commissions
- $798.6K
- Placement agents
- Aegis Capital Corp., Kingsbury Capital LLC
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$391.7KraisedMar 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$391.7KraisedMar 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dan J MitchellDirector
- Ralph E ChristoffersenDirector
- Timothy C RodellExecutive Officer, Director
- S Edward TorresDirector
- Augustine J LawlorDirector
- J William FreytagDirector
- Paul A MieyalDirector
- Kirk A ChristoffersenExecutive Officer
- C Jeffrey DekkerExecutive Officer
- Pennina SaferDirector
- Offering amount
- $391.7K
- Amount sold
- $391.7K
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Globeimmune raised?
- Globeimmune has disclosed $10M raised across 3 rounds.
- Where is Globeimmune headquartered?
- Globeimmune is headquartered in Louisville, US.